Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0DD3F
|
||||
Former ID |
DNC009032
|
||||
Drug Name |
(Sar)WTLNSAGYLLGPKK(Lys-myristoyl)K
|
||||
Indication | Discovery agent | Investigative | [529952] | ||
Structure |
Download2D MOL |
||||
Formula |
C102H169N23O23
|
||||
Canonical SMILES |
CCCCCCCCCCCCCC(=O)NCCCCC(C(=O)NC(CCCCN)C(=O)N)NC(=O)C(C<br />CCCN)NC(=O)C(CCCCN)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC<br />(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)CNC(=O)C(C)N<br />C(=O)C(CO)NC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(C(C)O)<br />NC(=O)C(CC3=CNC4=CC=CC=C43)OC(=O)CNC
|
||||
InChI |
1S/C102H169N23O23/c1-11-12-13-14-15-16-17-18-19-20-21-40-84(130)109-48-31-27-38-73(92(137)115-71(89(107)134)35-24-28-45-103)117-93(138)72(36-25-29-46-104)116-94(139)74(37-26-30-47-105)118-100(145)81-39-32-49-125(81)86(132)58-112-91(136)75(50-61(2)3)119-95(140)76(51-62(4)5)120-97(142)78(53-66-41-43-68(128)44-42-66)114-85(131)57-111-90(135)64(8)113-99(144)80(60-126)123-98(143)79(55-83(106)129)121-96(141)77(52-63(6)7)122-102(147)88(65(9)127)124-101(146)82(148-87(133)59-108-10)54-67-56-110-70-34-23-22-33-69(67)70/h22-23,33-34,41-44,56,61-65,71-82,88,108,110,126-128H,11-21,24-32,35-40,45-55,57-60,103-105H2,1-10H3,(H2,106,129)(H2,107,134)(H,109,130)(H,111,135)(H,112,136)(H,113,144)(H,114,131)(H,115,137)(H,116,139)(H,117,138)(H,118,145)(H,119,140)(H,120,142)(H,121,141)(H,122,147)(H,123,143)(H,124,146)/t64-,65+,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,88-/m0/s1
|
||||
InChIKey |
KPRCBTZIVGRZHY-OPDXRYIWSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Galanin receptor type 1 | Target Info | Inhibitor | [529952] | |
Galanin receptortype 2 | Target Info | Inhibitor | [529952] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.